首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Fortschritte der neurologie psychiatrie

缩写:FORTSCHR NEUROL PSYC

ISSN:0720-4299

e-ISSN:1439-3522

IF/分区:0.5/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1433条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Udo Bonnet Udo Bonnet
Cannabis hyperemesis syndrome (CHS) is a serious physical consequence of long-term, high-dose cannabis use, and a regional increase in incidence appears to be an indicator of an increase in cannabis use there. In addition to gradually incre...
Nina Unger,Christina J Molt,Lea K Heidelmann et al. Nina Unger et al.
Primary progressive aphasia (PPA) is a neurodegenerative disease that leads to progressive impairment of language and communication, with serious consequences for the daily lives of affected patients.As part of an international research col...
Matthias Guth Matthias Guth
Since 2020 physicians and psychotherapist in Germany can prescribe digital interventions. The interventions have to meet safety and data privacy requirements and must prove their effectiveness. Eight interventions are available in the field...
Oliver Pogarell,Gabriele Koller,Johannes Kramer Oliver Pogarell
Opioid use disorder (OUD) is a chronic, relapsing condition associated with high morbidity and mortality, primarily due to respiratory depression and overdose. In Germany, approximately 160,000 people are affected by opioid dependence, with...
Udo Bonnet Udo Bonnet
Cyclic vomiting attacks associated with chronic cannabis use were virtually unknown until 25 years ago. Following legalization of cannabis for recreational use in North America and the resulting increase in high-potency cannabis use, the pr...
Ulrike Reuner,Jürgen Dinger Ulrike Reuner
Morbus Wilson is a rare disease - if detected and treated early, the prognosis is favorable. Symptom freedom and a normal life expectancy are realistic treatment goals. If treatment starts too late, there are often functional impairments, a...
Ann-Katrin Schild,Claudia Bartels Ann-Katrin Schild
Since its introduction in 1999, the clinical syndrome Mild Cognitive Impairment (MCI) has been established in scientific and clinical practice. Technical and scientific advances made it necessary to regularly update research criteria, resul...